Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 402,579 | 952,137 | 333,949 | 456,535 | 758,505 |
| Marketable Securities | 982,725 | 723,141 | 743,010 | 665,041 | 531,604 |
| Receivables | N/A | 20,036 | 19 | 19 | 3,112 |
| Other current assets | 13,931 | 5,901 | 4,713 | 14,246 | 8,377 |
| TOTAL | $1,418,997 | $1,725,348 | $1,105,744 | $1,164,108 | $1,322,769 |
| Non-Current Assets | |||||
| PPE Net | 246,622 | 232,863 | 219,226 | 204,230 | 199,606 |
| Investments And Advances | 506,123 | 323,772 | 380,284 | 444,782 | 324,193 |
| Intangibles | 26,297 | 27,237 | 28,178 | 29,119 | 30,059 |
| Other Non-Current Assets | 44,805 | 42,569 | 28,079 | 24,569 | 23,940 |
| TOTAL | $823,847 | $626,441 | $655,767 | $702,700 | $577,798 |
| Total Assets | $2,242,844 | $2,351,789 | $1,761,511 | $1,866,808 | $1,900,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,831 | 12,891 | 17,936 | 12,028 | 12,873 |
| Accrued Expenses | 99,393 | 88,335 | 71,003 | 61,688 | 57,065 |
| Other current liabilities | 10,605 | 7,842 | N/A | N/A | N/A |
| TOTAL | $146,431 | $131,643 | $116,262 | $107,756 | $95,612 |
| Non-Current Liabilities | |||||
| Long Term Debt | 153,319 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 18,602 | 22,575 | 27,323 | 34,040 | 25,674 |
| Other Non-Current Liabilities | 41,686 | 197,100 | 159,815 | 160,045 | 159,760 |
| TOTAL | $211,343 | $219,356 | $187,715 | $188,851 | $181,523 |
| Total Liabilities | $357,774 | $350,999 | $303,977 | $296,607 | $277,135 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,748 | 2,735 | 2,708 | 2,506 | 2,499 |
| Common Shares | 547 | 547 | 502 | 501 | 494 |
| Retained earnings | -1,498,808 | -1,349,785 | -1,204,303 | -1,058,308 | -913,808 |
| Other shareholders' equity | -3,627 | -5,463 | -5,394 | -5,049 | -4,205 |
| TOTAL | $1,885,070 | $2,000,790 | $1,457,534 | $1,570,201 | $1,623,432 |
| Total Liabilities And Equity | $2,242,844 | $2,351,789 | $1,761,511 | $1,866,808 | $1,900,567 |